The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
from NDTV News - Latest https://ift.tt/3rRLYFo
Friday, December 10, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment